Medications commonly prescribed for alleviating fatigue in multiple sclerosis are no better than placebo and may cause side effects, according to a new randomised controlled trial. Conducted in two MS treatment centres in the US, an RCT involving 141 patients found that drugs such as methylphenidate, modafinil and amantadine had no significant effect on fatigue ...
Drugs for fatigue in MS are just placebo – with side effects
By Michael Woodhead
24 Nov 2020